Bioresorbable RFID capsule for assessing medication adherence.

ABSTRACT: Medication non-adherence remains a critical healthcare challenge, contributing to approximately 125,000 preventable deaths each year and incurring over $100 billion in annual costs in the United States. Current adherence assessment strategies are constrained by limited scalability, suboptimal patient acceptability, and environmental sustainability concerns. To address these limitations, we developed SAFARI (Smart Adherence via FARaday cage And Resorbable Ingestible), a bioresorbable, passive RFID system that enables precise monitoring of medication ingestion events. The platform incorporates a novel cellulose-metal particle-based radiofrequency (RF) shielding layer, effectively creating a Faraday cage that facilitates reliable signal detection. By employing fully biodegradable materials, S

SUBMITTER: Say MG 

PROVIDER: S-EPMC12783801 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature